Introduction
Low-grade inflammation has been proposed to be involved in the underlying pathogenesis of type 2 diabetes mellitus (T2DM) (Wang et al., 2013) . This manifestation is thought to be a result of an ongoing acute-phase response, primarily characterised by alterations in acute-phase proteins, such as C-reactive protein (CRP) (Pradhan, Manson, Rifai, Buring, & Ridker, 2001 ). More specifically, mediators of inflammation which include the interleukin 6 (IL-6) family of cytokines have been proposed to affect glucose homeostasis and metabolism directly and indirectly by action on skeletal muscle cells (Kristiansen & Mandrup-Poulsen, 2005) . Previous studies have established an inverse relationship between the amount of physical activity and proinflammatory cytokines in obesity, T2DM, and the metabolic syndrome (Hamer et al., 2012; Kasapis & Thompson, 2005) . Therefore, the beneficial effects of physical activity may be partly mediated by changes in the adipokines profile.
Recent advances in physical activity research have suggested that sedentary behaviour, defined as any waking sitting activity with a low energy expenditure, is an independent risk factor for several health outcomes (Biswas et al., 2015; Thorp, Owen, Neuhaus, & Dunstan, 2011; Wilmot et al., 2012) , including markers of inflammation (Healy, Matthews, Dunstan, Winkler, & Owen, 2011; Henson et al., 2013; Yates et al., 2012) . However, not all studies have confirmed an association with inflammation after adjustment for key lifestyle confounders (adiposity and/or moderate-to-vigorous physical activity (MVPA)) (Allison, Jensky, Marshall, Bertoni, & Cushman, 2012; Falconer et al., 2014; Yates et al., 2012) . These discrepancies may be partly explained by the population under investigation (high risk vs. general population), the potential interaction with physical activity, the measure of exposure (self-report vs. objective) or the statistical methods employed. Most previous investigations have examined each type of activity (sedentary, light, MVPA) without considering the time-dependent behaviours that are being displaced. Isotemporal substitution was developed as a methodology to study the time-substitution effects of one type of activity for another in a dataset consisting of continuous outcomes (Buman et al., 2014; Mekary, Willett, Hu, & Ding, 2009; Mekary et al., 2013) .
Given that time is finite, the heterogenous effects of an activity undertaken at a certain time point will be largely driven by the other activities being displaced.
Previous studies employing this method have found that reallocating time from sedentary time into physical activity is associated with improvements in insulin sensitivity (Yates et al., 2015) , glucose (Healy, Winkler, Owen, Anuradha, & Dunstan, 2015) , triglycerides (Buman et al., 2014) , markers of adiposity (Falconer, Page, Andrews, & Cooper, 2015) and all-cause mortality risk (Matthews et al., 2015) . However, only two studies have been able to isolate the effect of displacing sitting with standing using objective measurement Healy, Winkler, Owen, Anuradha, & Dunstan, 2015) , with both demonstrating beneficial associations with cardio-metabolic markers. This is important as habitual standing is behaviourally more ubiquitous than MVPA and may provide an appealing interventional target in the promotion of health. However, the associations of displacing sedentary time on markers of chronic low-grade inflammation have yet to be explored. Therefore, the aim of this paper is to extend previous research by quantifying reallocation from sitting into standing and stepping (split into light and MVPA intensity) in a population at high risk of T2DM and to determine whether results were modified high/low overall sitting time, length of sitting bout (<30 minutes or ≥30 minutes), sex or glucose regulation.
Methods

Participants
Participants at increased risk of T2DM (aged 30-75) were originally recruited through 10 primary care practices in Leicestershire, UK, in 2010 with an increased risk of impaired glucose regulation (IGR; any combination of impaired glucose tolerance (IGT) and/or impaired fasting glycaemia (IFG) or undiagnosed T2DM) were identified for recruitment using a modified version of the Leicester Risk Score . Those individuals scoring within the 90th percentile in each practice were invited to take part in the study. This approach has reasonable sensitivity and specificity for identifying participants with IGR . Individuals were unaware of their diabetes risk status before entering the study. We excluded those who had previously diagnosed T2DM, were currently taking steroids or were unable to take part in any walking. At baseline, individuals were randomised to usual care or the 3 hour Walking Away structured education programme with ongoing annual support (Yates, Davies et al., 2012) . This paper reports 36-month data from 372 participants, collected 2013-2014 as this was the only time point at which participants wore the activPAL3 TM device. The trial details and results have been published in detail elsewhere (Yates et al., 2016 (Winkler et al., 2016) . Heatmaps of the included and excluded data were created and visually checked. The self-reported wake and sleep times were also referred to if any data was coded incorrectly. A valid day was defined as a day with <95% spent in any one behaviour (eg, standing or sitting), >500 steps and ≥10 hours of waking hours data. Participants were required to have at least four valid days of data to be included in the analysis. For isotemporal analysis, data are expressed in units of 60 min·d -1 .
Demographic, anthropometric and medication status
Body mass (Tanita TBE 611, Tanita, West Drayton, UK), height and waist circumference (midpoint between the lower costal margin and iliac crest) were measured to the nearest 0.1 kg and 0.5 cm, respectively. Information on current smoking status, medication and ethnicity was obtained following an interview administered protocol with a health care professional.
Biomarker measurements
Biomarkers were selected a priori. CRP was analysed using a high sensitivity (Minimum Interpretation Limit = 0.1 mg/L) HORIBA ABX clinical chemistry analyser. IL-6 was analysed using quantikine high-sensitivity enzyme-linked immonosorbent assays (R&D systems). Leptin was analysed using AlphaLISA no wash fluorescence immunoassay kits (Perkin Elmer). All ELISA and fluorescence immunoassays were conducted in replicate on the same sample and the average value obtained. If the intra-assay coefficient of variation exceeded 10% for leptin, the assay was repeated using the same technique. Similarly, the IL-6 assay was repeated if the concentration was >2 pg/ml and the coefficient of variation >20% or the concentration was <2 pg/ml and the coefficient of variation >25%.
Statistical Analysis
Forced-entry linear regression modelling employing an isotemporal substitution approach was used to quantify the association of substituting 60 minutes of sitting for standing, light and MVPA stepping on markers of chronic low-grade inflammation. We chose 60 minute blocks as previous experimental and epidemiological work has demonstrated that breaking sitting time with 60 minutes of either standing or walking across the day significantly reduces the postprandial response in several markers of cardio-metabolic health in high risk of T2DM individuals (Henson et al., 2016; Yates et al., 2015) .
In order to investigate the association between sitting time and markers of chronic low grade inflammation, isotemporal substitution requires that average waking wear time, standing activity and time in stepping activity (both light and MVPA) are simultaneously entered into a linear regression model; the resulting regression coefficient for standing activity and stepping activity represent the association of substituting a given unit of sitting time into each category. These models have been described in detail elsewhere (Buman et al., 2014; Mekary et al., 2009; Mekary et al., 2013) .
Model 1 was adjusted for measured potential confounding variables defined as treatment group (intervention/control), age (continuous), sex (male/female), ethnicity (White European/South Asian/other), smoking status (current smoker/former smoker/never smoked), medication status (beta-blocker (nonsteroidal anti-inflammatory drugs (NSAIDs), angiotensin-converting-enzyme (ACE) inhibitors and statin use; all yes/no). As obesity plays a central role in the expression of inflammatory markers (Wisse, 2004) , results were further adjusted for waist circumference (Model 2).
The derived indexes of inflammatory markers displayed non-normal distributions, therefore all dependent variables were log-transformed with resulting regression coefficients back transformed; displayed coefficients consequently represent the value by which the dependent variable is multiplied by for a given unit of time in standing or stepping activity.
As the association between sitting time and markers of cardio-metabolic health may be influenced by the patterns in which the total volume is accumulated, significant observations were followed up with interaction terms to assess associations between bout length of sitting time (sitting time accumulated in bouts <30 minutes or ≥30 minutes) and markers of inflammation. We also tested the interaction for high/low sitting time (based on the median split) and whether results differed based upon sex and IGR status. All interaction analyses were adjusted for the same covariates as the main analysis.
Assumptions of linearity for each model were verified and multicollinearity was checked using the variance inflation factor (VIF). VIF values in all models were less than 5 indicating that multicollinearity was low. P values of <0.05 were considered significant for main effects and p<0.1 for interactions. IBM SPSS Statistics v22.0 (Chicago, IL, USA) was used to conduct all statistical analyses.
Sensitivity analyses were also conducted to investigate whether results were affected if a different measure of adiposity (BMI) was used as a covariate in model 2. In order to be consistent with previous studies (Best et al., 2005; Lee et al., 2009 ), a sensitivity analysis also investigated whether results were affected by removing participants with a CRP level >10mg/L, as this may be indicative of acute inflammation (Ridker, 2003) .
A single activity model (not an isotemporal model) was also run in order to assess each activity component separately (e.g., sitting, standing and walking), without taking into account the other activity types.
Results
Of Following adjustment for various confounders, reallocating 60 minutes of sitting time for standing was associated with -5% (-9%, -1%) lower IL-6 levels;
p=0.013; -8% (-14%, 2%) lower CRP levels; p=0.110 and -3% (-7%, 1%) lower leptin levels; p=0.206. Even after adjusting for waist circumference the results for IL-6 remained significant (-4% (-7%, -1%; p=0.048)).
In the fully adjusted model, reallocating 60 minutes of sitting time for light stepping was associated with lower IL-6 (-28% (-46%, -4%; p=0.025)) only.
Conversely theoretically substituting 60 minutes of sitting for MVPA stepping was associated with lower CRP (-41% (-75%, -8%; p=0.032)), leptin (-24% (-34%, -12%; p≤0.001)) and IL-6 (-16% (-28%, -10%; p=0.036)) values (Table 2 ).
In the single partition model all measured behaviours (sitting, standing, light and MVPA walking) were associated with all markers of inflammation after adjustment for the covariates listed above. Generally, the strongest associations were seen for sitting (direct) and MVPA stepping (inverse). After further adjustment for waist circumference, all results remained significant with the exception of replacing 60 minutes of standing on CRP and leptin (Table S1 ).
Interaction analyses
There was no interaction by sex, IGR status or length of sitting bout (<30 minutes or ≥30 minutes) for any measure (p > 0.1 for all). However, the interaction for reallocating high /low sitting time to MVPA stepping was significant for IL-6 (p=0.017) and CRP (p=0.091). Results were only significant in those with high sitting time (>9.3h per day). Reallocating 60 minutes of sitting for MVPA stepping was associated with 42% lower CRP (-74%, -1%, p=0.048) and 26% lower IL-6 (-45%, -1%, p=<0.001) ( Table 3) . No interactions were found reallocating 60 minutes of sitting time for standing or light stepping (p values displayed in Table S2 ).
Results reported above were unaffected if BMI, rather than waist circumference was used in Model 2. From the 372 participants with CRP values, 39
(10.5%) had levels >10mg/L. After exclusion of these participants, the standardised beta-coefficients were largely unchanged across all markers of chronic low-grade inflammation (Table S3 ). However, of particular note, the significant associations between standing and light stepping with IL-6 were attenuated.
Discussion
This epidemiological study provides novel evidence on the replacement effects of sitting, standing and stepping on markers of chronic low-grade inflammation using statistical modelling. Our results indicate that in people at high risk of T2DM, replacing 60 minutes of sitting with equal amounts of either standing or stepping may yield beneficial associations upon markers of chronic-low grade inflammation; even after controlling for various confounding variables, including waist circumference. Overall, the greatest effects were shown when moving from sitting to MVPA stepping with those displaying the highest overall sitting time likely to accrue the greatest benefit.
This study extends previous research in high risk of T2DM individuals which demonstrated that theoretically reallocating short or prolonged sitting time with standing or stepping may positively influence 2-hour glucose, fasting and 2-hour insulin and insulin sensitivity (improvements ranging from 4-16%) . More specifically, results of this study show that reallocating 60 minutes of sitting to standing resulted in a 4% reduction in IL-6. Transitioning from sitting to light stepping resulted in a 28% reduction in IL-6. The results for MVPA stepping were more consistent, with significant improvements in CRP (-41%), IL-6 (-16%) and leptin (-24%). These findings are compatible with both epidemiological and early experimental work, which demonstrate that reducing sitting time by approximately 60 minutes per day is likely to be around the minimum needed to gain clinical benefit, with greater reductions (and intensity) resulting in greater health gain (Dunstan et al., 2012; Grontved & Hu, 2011; Henson et al., 2016; Matthews et al., 2015; Yates et al., 2015) . Therefore, along with messages related to accumulating at least 150 min/week of MVPA, individuals should be further encouraged to simply sit less and move more. This has been demonstrated in a recent epidemiological study which showed that physical activity of any intensity influences markers of metabolic health but the higher the intensity, the greater the potential improvement for a given physical activity duration (Jelleyman et al., 2017) .
For example, individuals in this study would need to carry out 3.5 times more standing than walking in order to get the same hypothetical health benefit for IL-6.
The beneficial association between IL-6 and standing is a novel finding and may suggest a link with low-grade inflammation. These findings are broadly consistent with previous research which has demonstrated cross-sectional associations between objectively measured (Henson et al., 2013) and self-reported (Yates et al., 2012) sedentary behaviour and IL-6, independent of MVPA.
Furthermore, an increase in ambulatory activity, is known to have a strong inverse correlation with sedentary behaviour (Healy et al., 2011) , and has been shown to be associated with reduced IL-6 in those with IGT, independent of obesity (Yates et al., 2010) . IL-6 is a multifunctional proinflammatory cytokine produced by immune and non-immune cells (mainly adipose tissue and skeletal muscle) which acts upon a wide range of tissues through the modulation of cell growth and differentiation (Pedersen, 2012) . Although primarily considered a proinflammatory hormone, it is known that the isoform released by skeletal muscle also has anti-inflammatory effects (Pedersen & Febbraio, 2012) . Given its pleiotropic nature, IL-6 is one of the few genuine myokines that are produced by and/or act upon skeletal muscle. In Despite many of the associations persisting after exclusion of participants with a CRP-level >10mg/L, the associations between standing and light stepping with IL-6 were attenuated. However, it could be argued that removal of such participants may exclude many with chronic inflammation who are at the highest risk for poor health outcomes. This is important as previous studies have demonstrated that >5% of the population exhibit such values at a given time-point (Alley et al., 2006; Visser, Bouter, McQuillan, Wener, & Harris, 1999) . This number may be further exacerbated by individuals who exhibit characteristics such as obesity, smoking and physical inactivity, all known risk factors for chronic inflammation.
Furthermore, it has been suggested that using CRP>10mg/L to distinguish between acute and chronic inflammation may lack sensitivity (Ishii et al., 2012) .
Nevertheless, caution needs to be applied when interpreting the results due to potential bias through acute inflammation.
Although CRP was beneficially associated with replacing 60 minutes of sitting for MVPA stepping, the association between moving from sitting to a standing posture or engaging in light stepping was found to be non-significant. This is largely unsurprising as CRP is considered a simple downstream mediator of the acute phase response and is primarily derived via IL-6 dependent hepatic biosynthesis, usually within 6 hours of the stimulus (Pradhan et al., 2001) . Therefore, transitioning from sitting to MVPA stepping may be a reflection of upstream changes in the inflammatory response that are detected by downstream CRP levels, even if CRP itself has no direct activity. Leptin is also considered a proinflammatory adipocytokine that belongs structurally to the IL-6 family of cytokines (Harle & Straub, 2006) . It is known that leptin is capable of directly regulating glucose and fatty acid metabolism in skeletal muscle and fat tissue (Wolsk, Mygind, Grondahl, whole-body glucose and lipid homeostasis, and are therefore implicated in the development of obesity, insulin resistance and T2DM (Karpe, Dickmann, & Frayn, 2011 ).
The subsequent reduction in leptin observed when moving from sitting to MVPA stepping may be associated with the elevated production of non-esterified fatty acids [NEFA] during activity, which has previously been shown to be associated with leptin levels (Ceddia, 2005) . This is consistent with experimental evidence demonstrating that walking attenuates the postprandial suppression in plasma NEFA concentrations in high risk of T2DM individuals (Henson et al., 2016) . In contrast, standing may not yield a sufficient stimulus in order to significantly alter lipid metabolism.
Importantly, the results for IL-6, CRP and leptin persisted after adjustment for waist circumference. Obesity-mediated cytokine production is an important and possible central mechanism for systemic elevations of these biomarkers (Wisse, 2004) . However, these results suggest a possible role in the expression of inflammatory markers which is autonomously mediated.
This study has multiple strengths; most notably it provides novel evidence in a high risk primary care population. Our unique cohort of individuals are broadly representative of those referred onto diabetes prevention programmes, therefore having direct relevance for future diabetes prevention. The objective measure of time spent sitting, standing and stepping is also a strength. The activPAL3 TM has been shown to have almost perfect correlation with direct observation for sitting, sitting to upright transitions and for detecting reductions in sitting (Kozey-Keadle et al., 2011; Kozey-Keadle, Libertine, Staudenmayer, & Freedson, 2012; Lyden et al., 2012) .
That said, the ActivPAL may not represent the full range of activities undertaken, since it does not include upper body activities. A further limitation of our work was that the exposures were only carried out at one time-point (up to 7 days), which precludes the drawing of causal inferences and may not be an accurate reflection of habitual activity. Furthermore, it is also possible that unmeasured lifestyle or demographic variables were confounding the observed relationships (e.g. alcohol intake). However, we adjusted for key medications and behaviours [smoking] known to affect inflammation and metabolic health. The cross-sectional design also means that the isotemporal substitution approach used in this study is not based on actual replacements of one activity for another; it should instead be viewed as a population 
